AstraZeneca(AZN) - 2023 Q3 - Earnings Call Presentation

9M and Q3 2023 Results Conference call and webcast for investors and analysts Forward-looking statements Inorder,amongotherthings,to utilisethe'safeharbour' provisionsoftheUSPrivate SecuritiesLitigationReform Act of 1995, AstraZeneca (hereafter ‘the Group’) provides the following cautionary statement: This document contains certain forward-looking statements with respect to the operations, performance and financial condition of the Group, including, among other things, statements about expected revenues, ma ...